milyon88com

milyon88com AP Business SummaryBrief at 6:30 p.m. ESTBy MICHAEL R. SISAK NEW YORK (AP) — Lawyers for Sean “Diddy” Combs tried for a third time Friday to persuade a judge to let him leave jail while he awaits his sex trafficking trial, but a decision won’t come until next week. Judge Arun Subramanian said at a hearing that he will release his decision on Combs’ latest request for bail after Combs’ lawyers and federal prosecutors file letters addressing outstanding issues. Those letters are due at noon on Monday, Subramanian said. Combs’ lawyers pitched having him await trial under around-the-clock surveillance either his mansion on an island near Miami Beach or — after the judge scoffed at that location — an apartment on Manhattan’s Upper East Side. Their plan essentially amounts to putting Combs on house arrest, with strict limits on who he has contact with. But prosecutors argue that Combs has routinely flouted jail rules and can’t be trusted not to interfere with witnesses or the judicial process. “The argument that he’s a lawless person who doesn’t follow instructions isn’t factually accurate,” Combs lawyer Anthony Ricco argued. “The idea that he’s an out-of-control individual who has to be detained isn’t factually accurate.” Combs, 55, has pleaded not guilty to charges that he coerced and abused women for years with help from a network of associates and employees while silencing victims through blackmail and violence, including kidnapping, arson and physical beatings. His trial is slated to begin May 5. The Bad Boy Records founder remains locked up at a Brooklyn federal jail, where he spent his Nov. 4 birthday. Two other judges previously concluded that Combs would be a danger to the community if he is released and an appeals court judge last month denied Combs’ immediate release while a three-judge panel of the 2nd U.S. Circuit Court of Appeals weighs his bail request. Friday’s hearing was the second time Combs was in court this week. On Tuesday, a judge blocked prosecutors from using as evidence papers that were seized from his cell during jail-wide sweep for contraband and weapons at the Metropolitan Detention Center in Brooklyn. As he entered through a side door, Combs waved to relatives including his mother and several of his children in the courtroom gallery, tapping his hand to his heart and blowing kisses at them. He then hugged his lead attorney, Marc Agnifilo, before taking a seat at the defense table. He was not handcuffed or shackled and wore a beige jail uniform, occasionally pulling a pair of reading glasses from his pocket as he peered at papers in front of him. Prosecutors maintain that no bail conditions will mitigate the “risk of obstruction and dangerousness to others” of releasing Combs from jail. Prosecutors contend that while locked up the “I’ll Be Missing You” artist has orchestrated social media campaigns aimed at tainting the jury pool. They allege that he has also attempted to publicly leak materials he thinks would be helpful to his case and is contacting potential witnesses via third parties. “Simply put, the defendant cannot be trusted,” Assistant U.S. Attorney Christy Slavik argued. Combs’ lawyer Teny Geragos countered that, given the strict release conditions proposed, “it would be impossible for him not to follow rules.”None

Ionis Pharmaceuticals, Inc. ( NASDAQ:IONS – Get Free Report ) Director Michael R. Hayden purchased 5,000 shares of the business’s stock in a transaction on Monday, December 23rd. The stock was acquired at an average price of $36.22 per share, with a total value of $181,100.00. Following the purchase, the director now directly owns 35,219 shares in the company, valued at $1,275,632.18. This represents a 16.55 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website . Ionis Pharmaceuticals Price Performance Shares of Ionis Pharmaceuticals stock opened at $35.91 on Friday. The stock has a 50 day moving average price of $37.21 and a 200-day moving average price of $42.16. Ionis Pharmaceuticals, Inc. has a one year low of $33.33 and a one year high of $54.44. The stock has a market cap of $5.67 billion, a price-to-earnings ratio of -14.72 and a beta of 0.35. The company has a debt-to-equity ratio of 1.86, a quick ratio of 8.82 and a current ratio of 8.91. Wall Street Analyst Weigh In A number of research firms have recently weighed in on IONS. William Blair reaffirmed an “outperform” rating on shares of Ionis Pharmaceuticals in a research note on Friday, December 20th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $70.00 price objective on shares of Ionis Pharmaceuticals in a report on Thursday, September 26th. Needham & Company LLC reissued a “buy” rating and issued a $60.00 target price on shares of Ionis Pharmaceuticals in a report on Friday, December 20th. Guggenheim dropped their target price on shares of Ionis Pharmaceuticals from $70.00 to $65.00 and set a “buy” rating for the company in a research report on Wednesday, October 9th. Finally, StockNews.com downgraded shares of Ionis Pharmaceuticals from a “hold” rating to a “sell” rating in a report on Tuesday, November 12th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $60.65. Institutional Inflows and Outflows Hedge funds have recently bought and sold shares of the company. Geode Capital Management LLC boosted its stake in shares of Ionis Pharmaceuticals by 7.4% during the 3rd quarter. Geode Capital Management LLC now owns 2,668,358 shares of the company’s stock worth $106,922,000 after purchasing an additional 183,814 shares during the period. Great Point Partners LLC purchased a new position in shares of Ionis Pharmaceuticals during the second quarter valued at approximately $15,728,000. Charles Schwab Investment Management Inc. raised its holdings in shares of Ionis Pharmaceuticals by 8.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,443,020 shares of the company’s stock worth $57,807,000 after buying an additional 114,914 shares during the period. DRW Securities LLC bought a new stake in shares of Ionis Pharmaceuticals during the 2nd quarter worth approximately $2,429,000. Finally, Jacobs Levy Equity Management Inc. boosted its holdings in Ionis Pharmaceuticals by 13.6% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 650,779 shares of the company’s stock valued at $26,070,000 after acquiring an additional 77,909 shares during the period. Institutional investors own 93.86% of the company’s stock. Ionis Pharmaceuticals Company Profile ( Get Free Report ) Ionis Pharmaceuticals, Inc discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. Read More Receive News & Ratings for Ionis Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ionis Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter .BOONE, N.C. (AP) — South Carolina offensive coordinator Dowell Loggains has been hired as head coach at Appalachian State and will receive a five-year contract, athletic director Doug Gillin announced Saturday. The 44-year-old Loggains replaces Shawn Clark, for their first losing season since 2013. Loggains was South Carolina’s offensive coordinator for two seasons and an assistant at Arkansas, his alma mater, for two seasons before that. He spent 16 years in the NFL as offensive coordinator and quarterbacks coach for Tennessee, Cleveland, Chicago, Miami and the New York Jets. “He brings experience as a leader and play-caller at the highest levels of professional and college football,” Gillin said. “He is a great recruiter and believes strongly in building relationships. He is aligned with our core values of academic integrity, competitive excellence, social responsibility and world-class experience. This is a great day for App State.” Loggains’ offense at South Carolina featured LaNorris Sellers, one of the nation’s top dual-threat quarterbacks, and running back Raheim “Rocket” Sanders. Sellers and Sanders led the Southeastern Conference’s third-ranked rushing offense. Loggains spent the 2021 and 2022 seasons as Arkansas’ tight ends coach, and he worked with Sam Darnold, Jay Cutler, Mitchell Trubisky, Brian Hoyer and Vince Young during his time in the NFL. The Mountaineers, the preseason favorites in the Sun Belt Conference’s East Division, tied for fifth with a 3-5 record in league play. App State was 40-24 under Clark, but the Mountaineers have failed to reach a bowl game two of the past three seasons. ___ Get poll alerts and updates on the AP Top 25 throughout the season. Sign up . AP college football: and

Folgueiras has 27 in Robert Morris' 90-77 win against Saint Francis

Folgueiras has 27 in Robert Morris' 90-77 win against Saint Francis

LEXINGTON, Va. (AP) — Leo Colimerio had 15 points in Queens' 81-78 win against VMI on Saturday. Read this article for free: Already have an account? To continue reading, please subscribe: * LEXINGTON, Va. (AP) — Leo Colimerio had 15 points in Queens' 81-78 win against VMI on Saturday. Read unlimited articles for free today: Already have an account? LEXINGTON, Va. (AP) — Leo Colimerio had 15 points in Queens’ 81-78 win against VMI on Saturday. Colimerio had seven rebounds and five assists for the Royals (4-5). Jaxon Pollard scored 13 points while finishing 6 of 8 from the floor and added eight rebounds. Yoav Berman had 12 points and shot 4 of 7 from the field, including 3 for 6 from 3-point range, and went 1 for 4 from the line. A 3-pointer by TJ Johnson got VMI within 77-76 with 8 seconds remaining, but Nasir Mann’s layup gave Queens an important three-point lead with 6 seconds left. Rickey Bradley, Jr. led the way for the Keydets (5-6) with 19 points and four steals. TJ Johnson added 17 points, six rebounds and three steals for VMI. Augustinas Kiudulas also put up 15 points. ___ The Associated Press created this story using technology provided by Data Skrive and data from Sportradar. AdvertisementTrailblazing Canadian model Dayle Haddon dies from suspected carbon monoxide poisoning

How to buy Penn State Nittany Lions vs. Boise State Broncos Fiesta Bowl - Quarterfinal tickets